Xylem Inc. Deferred Foreign Income Tax Expense (Benefit)
Xylem Inc. (XYL) reported Deferred Foreign Income Tax Expense (Benefit) of $2.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-25
- Xylem Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was $2.00M, a 84.62% decline from fiscal 2024.
- Xylem Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was $13.00M.
- Xylem Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$22.00M.
- Xylem Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was -$9.00M, a 175.00% decline from fiscal 2021.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $2.00M 10-K · filed 2026-02-25 |
| 2024-12-31 | $13.00M 10-K · filed 2026-02-25 |
| 2023-12-31 | -$22.00M 10-K · filed 2026-02-25 |
| 2022-12-31 | -$9.00M 10-K · filed 2025-03-03 |
| 2021-12-31 | $12.00M 10-K · filed 2024-02-28 |
| 2020-12-31 | -$2.00M 10-K · filed 2023-02-24 |
| 2019-12-31 | -$83.00M 10-K · filed 2022-02-25 |
| 2018-12-31 | -$69.00M 10-K · filed 2021-02-26 |
| 2017-12-31 | -$14.00M 10-K · filed 2020-02-28 |
| 2016-12-31 | -$6.00M 10-K · filed 2019-02-22 |
| 2015-12-31 | -$11.00M 10-K · filed 2018-02-23 |
| 2014-12-31 | -$15.00M 10-K · filed 2017-02-23 |
| 2013-12-31 | -$8.00M 10-K · filed 2016-02-26 |
| 2012-12-31 | -$7.00M 10-K · filed 2015-02-26 |
| 2011-12-31 | -$16.00M 10-K · filed 2014-02-27 |
| 2010-12-31 | $10.00M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ITT INC. (ITT) | United States | $19.129B | 39.62 |
| IDEX CORP /DE/ (IEX) | United States | $16.848B | 32.33 |
| GRACO INC (GGG) | United States | $12.488B | 23.77 |
| FLOWSERVE CORP (FLS) | United States | $9.667B | 25.54 |
| GORMAN RUPP CO (GRC) | United States | $1.969B | 38.90 |
| AMPCO PITTSBURGH CORP (AP) | United States | $0.179B | -3.00 |